Cardiff Oncology (CRDF) Assets (2016 - 2025)
Cardiff Oncology (CRDF) has disclosed Assets for 15 consecutive years, with $61.9 million as the latest value for Q4 2025.
- Quarterly Assets fell 36.33% to $61.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $61.9 million through Dec 2025, down 36.33% year-over-year, with the annual reading at $61.9 million for FY2025, 36.33% down from the prior year.
- Assets hit $61.9 million in Q4 2025 for Cardiff Oncology, down from $63.8 million in the prior quarter.
- In the past five years, Assets ranged from a high of $149.5 million in Q4 2021 to a low of $61.9 million in Q4 2025.
- Historically, Assets has averaged $101.7 million across 5 years, with a median of $97.3 million in 2023.
- Biggest five-year swings in Assets: surged 996.64% in 2021 and later crashed 36.33% in 2025.
- Year by year, Assets stood at $149.5 million in 2021, then decreased by 22.3% to $116.2 million in 2022, then decreased by 29.74% to $81.6 million in 2023, then increased by 19.05% to $97.2 million in 2024, then plummeted by 36.33% to $61.9 million in 2025.
- Business Quant data shows Assets for CRDF at $61.9 million in Q4 2025, $63.8 million in Q3 2025, and $75.7 million in Q2 2025.